Tilray Brands (TLRY) closed at $1.18 on January 15th, unchanged from the previous day, despite a volatile trading session that saw the stock reach a high of $1.23 and a low of $1.17. The trading volume was 35,186,646 shares, slightly above the average, indicating heightened investor interest.
The stock's movement was influenced by mixed news. On January 15th, Roth Capital revised its FY2025 earnings estimate for Tilray, lowering it from ($0.18) to ($0.23) per share, reflecting concerns over the company's financial performance. This bearish outlook was compounded by Tilray's recent earnings report, which revealed a Q2 revenue miss, collecting $211 million against the expected $216.3 million. Despite a 9% y/y revenue growth, the company reported a net loss of $85 million, or $0.10 per share, under GAAP, highlighting ongoing profitability challenges.
On the positive side, Tilray's strategic investments in vapes and infused pre-rolls are expected to boost its Canadian cannabis sales, as noted by analysts from TD Cowen. Additionally, the expansion of Tilray's Happy Flower product line to 11 states in the U.S. is seen as a potential growth driver. However, concerns about cash burn and potential dilution remain, as discussed in various Reddit threads, with users expressing mixed sentiments about the company's long-term prospects.